The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
What Increase In Market Value Is Predicted For The Breast Biopsy Market During The 2026–2030 Period?
The breast biopsy market has experienced significant expansion over recent years. It is anticipated to grow from $1.53 billion in 2025 to $1.65 billion in 2026, at a compound annual growth rate (CAGR) of 7.5%. The historical growth of this market can be attributed to several factors, including the limited availability of advanced biopsy systems, reliance on traditional surgical biopsy methods, increasing breast cancer incidence, growing hospital and diagnostic center infrastructure, and the adoption of ultrasound-guided procedures.
The breast biopsy market is poised for significant expansion in the foreseeable future. Its size is expected to climb to $2.17 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 7.2%. This anticipated growth during the forecast period is propelled by technological progress in liquid biopsy and imaging-guided systems, a heightened awareness regarding early breast cancer detection, the proliferation of diagnostic centers and hospitals, increased integration of AI and data analytics, and the emergence of personalized and precision medicine approaches. Key trends anticipated in the upcoming period involve a greater adoption of minimally invasive biopsy procedures, a rise in the application of liquid biopsy techniques, the development of imaging-guided biopsy systems, the broadening of breast cancer diagnostic and screening initiatives, and an intensified focus on patient safety and the accuracy of samples.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19348&type=smp
Which Strategic Drivers Are Supporting The Breast Biopsy Market Development?
The increasing incidence of breast cancer is anticipated to stimulate the expansion of the breast biopsy market in the coming years. Breast cancer is characterized as a malignant growth developing in the cells of breast tissue, capable of spreading to other bodily regions if not addressed swiftly. The rise in breast cancer cases is linked to elements such as extended life expectancy, enhanced diagnostic techniques, and greater public understanding of the condition. A breast biopsy serves to collect tissue specimens from questionable zones within the breast, aiding in the diagnosis and characterization of breast cancer. For example, in October 2025, as per Breastcancer.org, a US-based non-profit organization, projections for 2025 indicate that approximately 316,950 women are predicted to receive a diagnosis of invasive breast cancer, alongside around 59,080 new cases of non-invasive ductal carcinoma in situ (DCIS). Consequently, the escalating occurrence of breast cancer is fueling the development of the breast biopsy market.
How Does Segment Analysis Break Down The Breast Biopsy Market Structure?
The breast biopsy market covered in this report is segmented –
1) By Type: Biopsy Needles, Guidance Systems, Biopsy Tables, Localization Wires, Assay Kits, Liquid Biopsy Instruments, Other Types
2) By Image Guided Technology: Magnetic Resonance Imaging (MRI) Guided Breast Biopsy, Ultrasound Guided Breast Biopsy, Mammography Guided Stereotactic Biopsy, Computed Tomography (CT) Guided Biopsy, Other Image Guided Technologies
3) By Procedure: Needle Breast Biopsy, Open Surgical Breast Biopsy, Liquid Breast Biopsy
4) By Application: Hospitals, Clinics, Diagnostic Centers, Other Applications
Subsegments:
1) By Biopsy Needles: Core Biopsy Needles, Fine Needle Aspiration (FNA) Needles, Vacuum-Assisted Biopsy Needles, Automatic Biopsy Needles
2) By Guidance Systems: Ultrasound Guidance Systems, MRI Guidance Systems, Stereotactic Guidance Systems, Tomosynthesis Guidance Systems
3) By Biopsy Tables: Adjustable Biopsy Tables, Specialty Biopsy Tables, Imaging-Compatible Biopsy Tables
4) By Localization Wires: Hookwire Localization Devices, Radioguided Localization Wires, Magnetic Seed Localization Systems
5) By Assay Kits: Breast Cancer Assay Kits, Biomarker Detection Kits, Genetic Testing Kits for Breast Cancer
6) By Liquid Biopsy Instruments: Circulating Tumor Cell (CTC) Isolation Devices, Plasma DNA Isolation Kits, Liquid Biopsy Analysis Systems
7) By Other Types: Biopsy Adhesives, Specimen Collection and Transport Devices, Patient Management Systems
What Trends Are Influencing The Future Of The Breast Biopsy Market?
Leading companies in the breast biopsy marker market are focusing on developing innovative products, such as ultrasound-visible site markers, to improve lesion localization and decrease marker displacement during breast biopsy procedures. An ultrasound-visible site marker is a specially engineered implantable device that enhances the visualization of biopsy sites during imaging and provides stable localization for future surgical intervention. For instance, in August 2023, Mammotome, a US-based provider of breast biopsy and localization technologies, introduced HydroMark Plus. This new breast biopsy site marker offers enhanced lesion visibility on ultrasound, assisting radiologists and surgeons in accurately targeting biopsy sites while reducing the risk of marker displacement during subsequent surgical procedures. As the latest addition to Mammotome’s HydroMark portfolio, HydroMark Plus is designed for improved procedural reliability and is slated for nationwide availability in the U.S. by the end of the year. The product’s key features include high ultrasound conspicuity for easy detection, a minimized risk of movement within breast tissue, and suitability for a wide variety of breast imaging and interventional workflows. These attributes are aimed at improving clinical outcomes and procedural confidence for both physicians and patients.
Which Companies Are Engaged In The Breast Biopsy Market Environment?
Major companies operating in the breast biopsy market are Siemens Healthineers AG, Fujifilm Holdings Corporation, Becton Dickinson and Company BD, Koninklijke Philips, GE HealthCare Technologies Inc, Hologic Inc, Merit Medical Systems, Argon Medical Devices, Canon Medical Systems Corporation, Devicor Medical Products Inc, Planmed Oy, Menarini-Silicon Biosystems, Seno Medical Instruments Inc, Dilon Technologies Inc, INRAD Inc, Promaxo Inc, Cook Medical LLC, Boston Scientific Corporation, Stryker Corporation, Intact Medical Corporation, Scion Medical Technologies LLC, Galini SRL, Ethicon Surgical Technologies, Encapsule Medical Devices LLC, Cardinal Health Inc, Olympus Corporation, F Hoffmann-La Roche Ltd, Biocept Inc.
Access The Complete Breast Biopsy Market Report:
https://www.thebusinessresearchcompany.com/report/breast-biopsy-global-market-report
Which Area Represents The Largest Portion Of The Breast Biopsy Market?
North America was the largest region in the breast biopsy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the breast biopsy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access a Customized Breast Biopsy Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/customise?id=19348&type=smp
Browse Through More Reports Similar to the Global Breast Biopsy Market 2026, By The Business Research Company
Biopsy Devices Market Report 2026
https://www.thebusinessresearchcompany.com/report/biopsy-devices-global-market-report
Liquid Biopsy For Cancer Diagnostics Market Report 2026
Smart Biopsy Devices Market Report 2026
https://www.thebusinessresearchcompany.com/report/smart-biopsy-devices-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model